13F HOLDINGS REPORT (Amended)
Eversept Partners, LP
Quarter ended Q4 2023 · Filed November 8, 2023 · Accession 0001697013-23-000010
Total Value
$184.7M
Positions
54
Other Managers
0
Confidential Omitted
No
Holdings (54)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ZOGENIX INC | 98978L204 | 563,429 | $20.5M | 11.12% |
| 2 | GLAXOSMITHKLINE PLC | GLAXF | 529,484 | $20.4M | 11.04% |
| 3 | R1 RCM INC | 749397105 | 2,349,306 | $18.7M | 10.11% |
| 4 | AMARIN CORP PLC | AMRN | 1,263,407 | $17.2M | 9.31% |
| 5 | SANOFI | SNYNF | 306,242 | $13.3M | 7.20% |
| 6 | RADIUS HEALTH INC | 750469207 | 552,053 | $9.1M | 4.93% |
| 7 | AERIE PHARMACEUTICALS INC | 00771V108 | 232,790 | $8.4M | 4.55% |
| 8 | VERTEX PHARMACEUTICALS INC | VRTX | 36,492 | $6.0M | 3.27% |
| 9 | DANAHER CORP DEL | 235851102 | 47,804 | $4.9M | 2.67% |
| 10 | ABIOMED INC | 003654100 | 13,939 | $4.5M | 2.45% |
| 11 | SAREPTA THERAPEUTICS INC | SRPT | 40,494 | $4.4M | 2.39% |
| 12 | MYLAN N V | N59465109 | 158,600 | $4.3M | 2.35% |
| 13 | ARGENX SE | ARGX | 38,224 | $3.7M | 1.99% |
| 14 | MERCK & CO INC | MRK | 45,800 | $3.5M | 1.91% |
| 15 | ENSIGN GROUP INC | ENSG | 85,575 | $3.3M | 1.80% |
| 16 | ARENA PHARMACEUTICALS INC | 040047607 | 81,371 | $3.2M | 1.72% |
| 17 | TELIGENT INC NEW | 87960W104 | 2,247,476 | $3.1M | 1.67% |
| 18 | TESARO INC | 881569107 | 36,000 | $2.7M | 1.45% |
| 19 | ABBOTT LABS | ABLZF | 31,400 | $2.3M | 1.23% |
| 20 | FATE THERAPEUTICS INC | FATE | 165,000 | $2.1M | 1.15% |
| 21 | QIAGEN NV | QGEN | 55,300 | $1.9M | 1.03% |
| 22 | ILLUMINA INC | ILMN | 5,148 | $1.5M | 0.84% |
| 23 | GENOMIC HEALTH INC | 37244C101 | 23,866 | $1.5M | 0.83% |
| 24 | MYLAN N V | N59465109 | 55,000 | $1.5M | 0.82% |
| 25 | DECIPHERA PHARMACEUTICALS IN | 24344T101 | 69,700 | $1.5M | 0.79% |
| 26 | APELLIS PHARMACEUTICALS INC | APLS | 106,880 | $1.4M | 0.76% |
| 27 | LOXO ONCOLOGY INC | 548862101 | 10,000 | $1.4M | 0.76% |
| 28 | BIOSPECIFICS TECHNOLOGIES CO | 090931106 | 22,000 | $1.3M | 0.72% |
| 29 | BIOCRYST PHARMACEUTICALS | BCRX | 163,959 | $1.3M | 0.72% |
| 30 | XENON PHARMACEUTICALS INC | XENE | 205,104 | $1.3M | 0.70% |
| 31 | ARRAY BIOPHARMA INC | 04269X105 | 90,412 | $1.3M | 0.70% |
| 32 | FOAMIX PHARMACEUTICALS LTD | M46135105 | 294,660 | $1.1M | 0.57% |
| 33 | AFFIMED N V | N01045108 | 335,774 | $1.0M | 0.57% |
| 34 | CARETRUST REIT INC | CTRE | 51,264 | $956,199 | 0.52% |
| 35 | ASCENDIS PHARMA A S | ASND | 15,254 | $955,663 | 0.52% |
| 36 | TRICIDA INC | 89610F101 | 40,522 | $955,509 | 0.52% |
| 37 | ARQULE INC | ARQ | 344,618 | $954,592 | 0.52% |
| 38 | PUMA BIOTECHNOLOGY INC | PBYI | 42,301 | $860,825 | 0.47% |
| 39 | SAGE THERAPEUTICS INC | 78667J108 | 8,271 | $792,279 | 0.43% |
| 40 | ANTHEM INC | ELV | 2,300 | $604,049 | 0.33% |
| 41 | AMICUS THERAPEUTICS INC | FOLD | 62,750 | $601,145 | 0.33% |
| 42 | NATERA INC | NTRA | 39,539 | $551,964 | 0.30% |
| 43 | CENTENE CORP DEL | CNC | 4,300 | $495,790 | 0.27% |
| 44 | ALBIREO PHARMA INC | 01345P106 | 18,029 | $442,251 | 0.24% |
| 45 | DICERNA PHARMACEUTICALS INC | 253031108 | 41,074 | $439,081 | 0.24% |
| 46 | FLUIDIGM CORP DEL | LAB | 50,455 | $434,922 | 0.24% |
| 47 | CYMABAY THERAPEUTICS INC | 23257D103 | 47,096 | $370,646 | 0.20% |
| 48 | INVACARE CORP | 461203101 | 73,902 | $317,779 | 0.17% |
| 49 | SEASPINE HLDGS CORP | SE | 15,459 | $281,972 | 0.15% |
| 50 | TG THERAPEUTICS INC | TGTX | 65,000 | $266,500 | 0.14% |
| 51 | OPIANT PHARMACEUTICALS INC | 683750103 | 13,901 | $200,869 | 0.11% |
| 52 | AQUINOX PHARMACEUTICALS INC | 03842B101 | 73,717 | $159,229 | 0.09% |
| 53 | EPIZYME INC | 29428V104 | 25,449 | $156,766 | 0.08% |
| 54 | CONFORMIS INC | 20717E101 | 136,851 | $48,993 | 0.03% |